The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation

The management of recurrent hepatocellular carcinoma untreatable with surgical options is based on systemic therapy with sorafenib. Due to the high rates of adverse events connected to the therapy with sorafenib, metronomic capecitabine seems a promising strategy for these patients. We analyzed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravaioli, Matteo, Cucchetti, Alessandro, Pinna, Antonio Daniele, De Pace, Vanessa, Neri, Flavia, Barbera, Maria Aurelia, Maroni, Lorenzo, Frega, Giorgio, Palloni, Andrea, De Lorenzo, Stefania, Ripoli, Maria Cristina, Pantaleo, Maria Abbondanza, Cescon, Matteo, Del Gaudio, Massimo, Brandi, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595852/
https://www.ncbi.nlm.nih.gov/pubmed/28900245
http://dx.doi.org/10.1038/s41598-017-11810-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595852/
https://www.ncbi.nlm.nih.gov/pubmed/28900245
http://dx.doi.org/10.1038/s41598-017-11810-z

Ejemplares similares